Experimental Weight-Loss drug tested in chinese volunteers
NCT ID NCT06916091
Summary
This early-stage study tested the safety and side effects of a single injection of an experimental drug called Eloralintide in 30 Chinese adults with obesity or overweight. Researchers monitored participants for about 10 weeks to see how their bodies handled the drug and to check for any health problems. The main goal was to gather initial safety data before testing the drug's effectiveness for weight management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore
Conditions
Explore the condition pages connected to this study.